(Q43049360)

12 November 2017

title

A controlled trial of tick-borne encephalitis vaccination in patients with multiple sclerosis (English)

1 reference

12 November 2017

0 references

tick-borne encephalitis

1 reference

Ulf Baumhackl

1

1 reference

12 November 2017

Claudia Franta

2

1 reference

12 November 2017

Johann Retzl

3

1 reference

12 November 2017

Erich Salomonowitz

4

1 reference

12 November 2017

Gerald Eder

5

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

12 November 2017

1 reference

12 November 2017

volume

21 Suppl 1

1 reference

12 November 2017

page(s)

S56-61

1 reference

Is measles vaccination a risk factor for inflammatory bowel disease?

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Hepatitis B vaccination and the risk of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Difficulties in assessing the relationship, if any, between mumps vaccination and diabetes mellitus in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Neurological complications to vaccination against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Clinical viral infections and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Multiple sclerosis and antecedent infections: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Influenza immunization in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Neurological complications of swine influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

The pathogenesis of multiple sclerosis: a commentary

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Inter- and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Frequency and significance of antinuclear antibodies in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

Transient virus infection and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900815-0

7 January 2021

10.1016/S0264-410X(02)00815-0

Identifiers

DOI

1 reference

12 November 2017

1 reference